|
KIAA0182 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.865600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.138000E-01 |
| Normal-vs-Stage2 |
8.289600E-01 |
| Normal-vs-Stage3 |
4.498600E-01 |
| Normal-vs-Stage4 |
2.510100E-02 |
| Stage1-vs-Stage2 |
4.876400E-01 |
| Stage1-vs-Stage3 |
7.343800E-01 |
| Stage1-vs-Stage4 |
2.476600E-01 |
| Stage2-vs-Stage3 |
4.753800E-01 |
| Stage2-vs-Stage4 |
1.102020E-01 |
| Stage3-vs-Stage4 |
3.184400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.327400E-01 |
| Normal-vs-AfricanAmerican |
7.063600E-01 |
| Normal-vs-Asian |
6.793600E-01 |
| Caucasian-vs-AfricanAmerican |
8.898000E-01 |
| Caucasian-vs-Asian |
7.179800E-01 |
| AfricanAmerican-vs-Asian |
7.656000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.120800E-01 |
| Normal-vs-Female |
8.112000E-01 |
| Male-vs-Female |
9.341000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.521800E-02 |
| Normal-vs-Extreme_Weight |
3.325200E-01 |
| Normal-vs-Obese |
4.210400E-01 |
| Normal-vs-Extreme_Obese |
1.225570E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.388800E-01 |
| Normal_Weight-vs-Obese |
2.697600E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.870400E-01 |
| Extreme_Weight-vs-Obese |
1.099180E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.264000E-01 |
| Obese-vs-Extreme_Obese |
6.649700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.790950E-01 |
| Normal-vs-Age(41-60Yrs) |
6.896200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.777000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.684260E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.804020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.278500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.792110E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.214990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.761600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.343600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.084000E-01 |
| Normal-VS-Type2 PRCC |
1.877040E-03 |
| Normal-VS-KIRP CIMP |
9.932100E-02 |
| Normal-VS-Unclassified PRCC |
8.299400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.28880000000742E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.597700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.472400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.623720E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.044010E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.037800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.558600E-03 |
| Normal-vs-N1 |
9.810400E-01 |
| Normal-vs-N2 |
9.262200E-02 |
| N0-vs-N1 |
4.225700E-02 |
| N0-vs-N2 |
9.054800E-01 |
| N1-vs-N2 |
3.590000E-01 |
|
|
